In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tzamal Medical Group Ltd.

www.tzamal-medical.co.il

Latest From Tzamal Medical Group Ltd.

Deal Terminations Not The End Of The Road For Licensed Drugs

Post-deal termination, approximately 14% of the drugs from those alliances go on to be approved, and of those still in development, nearly two-thirds advance at least one phase. Third in a series of follow-ups to IN VIVO’s 2014 study comparing/contrasting likelihood of approval and up-front payments on alliances, and the outcomes of relevant deals.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Tzamal Medical Group Ltd.
  • Senior Management
  • Joshua Katz, Managing Dir.
    Eli Dadkha, Finance Manager
  • Contact Info
  • Tzamal Medical Group Ltd.
    Phone: 73 7151111
    20 Hamagshimim St.
    Kiryat Matalon
    Petah Tikvah, 49170
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register